BioHealth News
Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment
Collaboration Aims to Develop First Intranasal Therapy for Mild Traumatic Brain Injury Aka Concussion, Establishing a Comprehensive Test-to-Treat Platform SARASOTA, Fla. and RICHMOND, Va.,…
Read More
Children’s National and Compremium partner on pediatric medtech innovation
WASHINGTON, DC / BERN, SWITZERLAND - Children’s National Hospital and Compremium AG entered into a strategic partnership to develop and commercialize cutting-edge medical technologies…
Read More
GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced ultraRapid Whole Genome Sequencing, offering accelerated and comprehensive…
Read More
Baltimore’s Elixirgen Therapeutics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation
BALTIMORE, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on treating rare diseases, today announced that the U.S.…
Read More
SSTI – Useful Stats: Which businesses are potentially impacted by the NIH F&A rate change?
By Conor Gowder & Mark Skinner The Feb. 7, 2025, memo from the NIH Office of the Director (NOT-OD-25-068), now on hold because of…
Read More
TEDCO Announces FY2025 SBIR/STTR Proposal Lab Cohort
The sixth cohort will undergo the first iteration of the program’s new structure COLUMBIA, Md., (February 13, 2025) — TEDCO, Maryland’s economic engine for…
Read More
Volition: Celebrating women in science: empowering the future
As we celebrate Women in Science Day and Women’s History Month, we are proud to spotlight the women of Volition. From driving groundbreaking innovation…
Read More
MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs
TG Therapeutics to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support the development and commercialization of azer-cel, its allogeneic CD19 CAR T…
Read More
Maryland Economic Headwinds? Time to Invest in Economies of the Future
By Brian Darmody: While the Maryland economy is facing budget uncertainties, the state can help surmount these challenges by growing private growth industries, converting…
Read More
New GW Study Highlights Importance of Measuring Well-Being in Mental Health Research
New Study Highlights Importance of Measuring Well-Being in Mental Health Research WASHINGTON (February 10, 2025) – A new study published in Nature Mental Health…
Read More
Previous BHCR Crab Trap Winner LifeSprout Completes CE Mark Submission for Lumina™, a Next-Generation Aesthetics Dermal Filler
BALTIMORE, Jan. 23, 2025 /PRNewswire/ -- LifeSprout, a privately held regenerative medicine company founded with technology licensed from Johns Hopkins University, today announced it has filed for…
Read More
Senseonics Completes CE Mark Submission for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor
GERMANTOWN, Md., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing…
Read More
Investing in BioHealth: Dr. Deborah Hemingway on Building Maryland’s Commercialization Hub on BioTalk
[vc_row type="in_container" full_screen_row_position="middle" column_margin="default" column_direction="default" column_direction_tablet="default" column_direction_phone="default" scene_position="center" text_color="dark" text_align="left" row_border_radius="none" row_border_radius_applies="bg" overlay_strength="0.3" gradient_direction="left_to_right" shape_divider_position="bottom" bg_image_animation="none"][vc_column column_padding="no-extra-padding" column_padding_tablet="inherit" column_padding_phone="inherit" column_padding_position="all" column_element_spacing="default" background_color_opacity="1" background_hover_color_opacity="1" column_shadow="none"…
Read More
APT – SCOPE Summit 2025: Emmes’ Peter Ronco on Small Biopharma & Clinical Trial Partnerships
In an interview with ACT Associate Editor Don Tracy, Peter Ronco, CEO, Emmes, discusses the "Choosing the Right Allies: Ensuring Clinical Trial Success for…
Read More
Children’s National Hospital and Virginia Tech Expand Research Partnership to Advance Pediatric Health
Newswise — Children’s National Hospital and Virginia Tech are expanding their research partnership, building on a successful collaboration established in 2019. This partnership will…
Read More